page_banner

MMXIX-nCoV Neutralizing Antibody Test Kit (colloidale aurum modum)

MMXIX-nCoV Neutralizing Antibody Test Kit (colloidale aurum modum)

Description:

Commodum
Velox
late adsuesco assuesco
Securus agunt, magis opus est


Product Detail

PICTURAE

Download

Product Tags

Introductio

Spicula dapibus notus est scopo antigenico pro evolutione vaccini contra 2019-nCoV, et dapibus RBD of S epitopae principalis est.

Plus quam 180 candidati vaccini, pluribus diversis suggestis innixi nunc in evolutione contra 2019-nCoV sunt.

S interdum maior est scopo corrumpendi elementorum;

Multi ex his elementis corrumpendis RBD of S interdum oppugnant.

Quomodo iudicare efficientiam 2019-nCoV vaccine?--- Neutralizing Antibody Test

commoda

Pre probatio vaccini
Candidati ante vaccinationem possunt deprehendere ad anticorpus RBD neutralisandum determinare utrum vaccinatio necessaria sit;

Most vaccina teguntur
Deprehendere potest corrumpendi elementorum quae a plerisque vaccinis in foro producta sunt;

Ieiunium et opportunum
Operatio simplex est, nullo instrumento detecto opus est, eventus intra 15 minutas obtineri potest.

Lepidium sativum munus
Distinguendum est neutralizans anticorpus 2019-nCoV productum ab 2019-nCoV vaccinum vel anticorpus ab 2019-nCoV infectio quaedam vaccina producta, ut vector Viralis (Non-replicating) vaccinum, RNA basi vaccinum et interdum subunitum vaccinum ;

Totum sanguinem test
Totus sanguis expertus operationem commodiorem facit.

Components

Components

Pelagus Rebus

Quantitas loading (specification)

1 T/Kit

5 T/Kit

Test card

Testi habena continens colloidal aurum intitulatum anti-humanum IgG anticorpus, auri colloidale intitulatum anti-galli IgY anticorporis, 2019-nCoV S-RBD dapibus recombinantibus, 2019-nCoV recombinante N interdum, Pullus IgY antibody

1 pc*

5 at pede

Sample diluent

0.01M Phosphas solutionis quiddam, 0.5% Twen-20

0.5mL

2.5mL

Euismod

Hecin tenui Serum virus neutralization clinicae test Totalis
Positivum Negative
Positivum 84 17 101
Negative 8 190 198
Totalis 92 207 299
Fusce sensus 84/92 91.30% (95%CI: 83.58%~96.17%)
Fusce specificity 190/207 91.79% (95%CI: 87.18%~95.14%)
Sagacitas 274/299 91.64% (95%CI: 87.90%~94.52%)

Hecin gerens euismod contra methodum comparatorem in speciminibus seri/plasma.

Hecin tenui Serum virus neutralization clinicae test Totalis
Positivum Negative
Positivum 84 16 100
Negative 8 191 199
Totalis 92 207 299
Fusce sensus 84/92 91.30% (95%CI: 83.58%~96.17%)
Fusce specificity 191/207 92.27% (95%CI: 87.75%~95.52%)
Sagacitas 275/299 91.97% (95%CI: 88.29%~94.79%)

Hecin gerens euismod contra Comparatorem Methodi speciminum integrorum sanguinis.

Locum applicationis

Pre vaccination

Decernite an novis coronavirus inficiantur et an vaccinantur adhuc opus sit;

Vaccination tempus

Determinare an efficax novum anticorpus neutralising producatur;

Nuper scaena inoculationis

Iuxta epidemiam aream 2019-nCoV, suadet deprehendere exsistentiam MMXIX-nCoV corrumpere anticorpum regulariter singulis tribus mensibus.

Compare with MMXIX-nCoV S-RBD Neutralizing Antibody Test Kit (Colloidal Aurum Methodus)

Accipe S-RBD IgG, N dapibus Igg eventus test simul, analysin analysin analysi.

Accipere S-RBD Igg

*Opus ulteriore probatione: Commendatur ut retexamus vel experiamur cum aliis productis methodologiae densitatis altioris praecisione.

Test De modo procedendi

Test Procedure1

Registration Certificatorium

Registration certificatorium
Registration certificatorium
Registration certificatorium2

Product speciem

Hecin JT09-Product Picture

Hecin JT09-50PCS Product Picture


  • Priora:
  • Deinde:

  • JT09- 50T

    50t9 50t1 50t2 50t3 50t4 50t5 50t6 50t7 50t8

    Epistulam tuam hic scribe et mitte nobis